Inventor
STIRN SCOTT
US10 patents
⚠️ This page may combine multiple inventors who share the name “STIRN SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
3 patentsUS9522133B2Dec 20, 2016
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC9 citations83
US10226471B2Mar 12, 2019
Modified-release dosage forms of 5-HT2C agonists useful for weight management
ARENA PHARM INC1 citations59
US10463676B2Nov 5, 2019
Modified-release dosage forms of 5-HT2C agonists useful for weight management
ARENA PHARM INC0 citations48
JONES ROBERT M
2 patentsUS8580841B2Nov 12, 2013
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
JONES ROBERT M21 citations92
US9085581B2Jul 21, 2015
Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof
JONES ROBERT M6 citations82
BLACKBURN ANTHONY C
2 patentsNEUROCRINE BIOSCIENCES INC
2 patentsUS12582634B2Mar 24, 2026
Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine
NEUROCRINE BIOSCIENCES INC0 citations57
US12486250B2Dec 2, 2025
Muscarinic receptor 4 antagonists and methods of use
NEUROCRINE BIOSCIENCES INC0 citations55